|
|
Volumn 6, Issue 6, 2010, Pages 877-880
|
|
Selective serotonin reuptake inhibitors and adjuvant tamoxifen therapy: risk of breast cancer recurrence and mortality.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 HYDROXYNORTAMOXIFEN;
4-HYDROXY-N-DESMETHYLTAMOXIFEN;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
CITALOPRAM;
CYTOCHROME P450 2D6;
DRUG DERIVATIVE;
ESTROGEN;
SEROTONIN UPTAKE INHIBITOR;
TAMOXIFEN;
ALLELE;
BIOTRANSFORMATION;
BLOOD;
BREAST TUMOR;
DENMARK;
DEPRESSION;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG INTERACTION;
EDITORIAL;
FEMALE;
GENETICS;
HUMAN;
METABOLISM;
MORTALITY;
NEOPLASM;
PROGNOSIS;
RECURRENT DISEASE;
ALLELES;
ANTINEOPLASTIC AGENTS, HORMONAL;
BIOTRANSFORMATION;
BREAST NEOPLASMS;
CITALOPRAM;
CYTOCHROME P-450 CYP2D6;
DENMARK;
DEPRESSION;
DRUG INTERACTIONS;
ESTROGENS;
FEMALE;
HUMANS;
NEOPLASMS, HORMONE-DEPENDENT;
PROGNOSIS;
RECURRENCE;
SEROTONIN UPTAKE INHIBITORS;
TAMOXIFEN;
|
|
EID: 77957275210
PISSN: None
EISSN: 17448301
Source Type: Journal
DOI: 10.2217/fon.10.65 Document Type: Editorial |
|
Times cited : (16)
|
|
References (0)
|
